Multicenter, single-arm, phase II trial of camrelizumab and chemotherapy as neoadjuvant treatment for locally advanced esophageal squamous cell carcinoma (vol 10, e004291, 2022)

被引：0
|
作者：
Liu, J.
Yang, Y.
Liu, Z.
机构：
来源：
JOURNAL FOR IMMUNOTHERAPY OF CANCER | 2022年 / 10卷 / 06期
关键词：
D O I：
10.1136/jitc-2021-004291corr1
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Sintilimab combined with definitive chemoradiotherapy in locally advanced esophageal squamous cell carcinoma: A single-arm, multicenter, phase 2 trial
    Lyu, Jiahua
    Li, Tao
    Liang, Long
    Li, Churong
    Jia, Hongyuan
    Qi, Yunxiang
    Zheng, Xiumei
    Fan, Yu
    Kuang, Hao
    Bai, Hansong
    Zhang, Wanli
    Lu, Guangbing
    Wang, Gan
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [22] Sintilimab Combined with Definitive Chemoradiotherapy in Locally Advanced Esophageal Squamous Cell Carcinoma: A Single-Arm, Multicenter, Phase 2 Trial
    Lv, J.
    Liang, L.
    Li, C.
    Jia, H.
    Xiang, Q.
    Zheng, X.
    Fan, Y.
    Kuang, H.
    Bai, H. S.
    Zhang, W.
    Lu, G.
    Wang, G.
    Li, T.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2024, 120 (02): : E467 - E468
  • [23] Camrelizumab combined with paclitaxel and nedaplatin in the first-line treatment of locally advanced/advanced esophageal squamous cell carcinoma: A phase II, single-arm, exploratory research
    Wang, X.
    Ma, J.
    Zhang, J.
    Yang, Y.
    Zheng, D.
    Liang, H.
    Zhang, L.
    Xin, Y.
    Ling, X.
    Fang, C.
    Jiang, H.
    Zheng, W.
    ANNALS OF ONCOLOGY, 2021, 32 : S1400 - S1400
  • [24] CAMRELIZUMAB COMBINED WITH PACLITAXEL AND NEDAPLATIN IN THE FIRST-LINE TREATMENT OF LOCALLY ADVANCED/ADVANCED ESOPHAGEAL SQUAMOUS CELL CARCINOMA: A PHASE II, SINGLE-ARM, EXPLORATORY RESEARCH
    Ma, Jianqun
    Zhang, Jinfeng
    Yang, Yingnan
    Zheng, Dayong
    Wang, Xiaoyuan
    Liang, Hao
    Zhang, Luquan
    Xin, Yanzhong
    Ling, Xiaodong
    Fang, Chengyuan
    Jiang, Hao
    Zheng, Wei
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 : A437 - A437
  • [25] Camrelizumab plus chemotherapy as neoadjuvant treatment for resectable locally advanced esophageal squamous cell carcinoma (LA-ESCC): A single-center, randomized, phase II trial
    Lu, Zhihao
    Cao, Yanshuo
    Dai, Liang
    Dong, Fengxiao
    Shen, Lin
    CANCER RESEARCH, 2024, 84 (07)
  • [26] Three courses of neoadjuvant camrelizumab combined with chemotherapy in locally advanced esophageal squamous cell carcinoma (ESCC): A prospective phase II clinical trial
    Yang, G.
    Sun, X.
    Yang, H.
    Luo, G.
    Zheng, Y.
    Huang, M.
    Wang, Z.
    Cai, P.
    He, H.
    Xiang, J.
    Cai, M.
    Fu, J.
    Liu, Q.
    Yi, H.
    Zhong, J.
    Huang, Y.
    Guo, Q.
    Zhang, X.
    ANNALS OF ONCOLOGY, 2022, 33 (07) : S1122 - S1122
  • [27] Toripalimab plus Chemotherapy and Radiotherapy for Treatment-Naive, Advanced Esophageal Squamous Cell Carcinoma: A Single-Arm Phase II Trial
    Wang, Q.
    Wu, L.
    Liang, L.
    Wang, Y.
    Peng, L.
    Han, Y.
    Li, T.
    Lang, J.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2024, 120 (02): : E495 - E495
  • [28] Neoadjuvant camrelizumab combined with chemotherapy and apatinib for locally advanced thoracic esophageal squamous cell carcinoma (ESCC): A single-arm, open-label, phase Ib study.
    Wang, Zhen
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [29] Induction chemotherapy plus camrelizumab followed by concurrent chemoradiotherapy in patients with unresectable locally advanced esophageal squamous cell carcinoma (ImpactCRT): A single-arm, phase. trial
    Peng, Fang
    Bao, Yong
    Cheng, Chao
    Niu, Shaoqing
    Song, Wu
    Li, Yin
    Yu, Honglan
    Xing, Xiangbin
    Feng, Shiting
    Wang, Xiaoyan
    Lian, Huimin
    Yu, Tiantian
    Wu, Jialiang
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [30] Neoadjuvant anlotinib combined with penpulimab for resectable locally advanced esophageal squamous cell carcinoma (ESCC): A prospective, single-arm, phase II trial.
    Chen, Yueyun
    Ding, Zhen-Yu
    Yuan, Yong
    Yang, Yu-Shang
    Lin, Zhen
    Tian, Jiangfang
    Liu, Ting
    Yue, Zheng
    Shi, Hua-Shan
    Hu, Yang
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (3_SUPPL) : 352 - 352
12345